Corrigendum to “PCSK9 inhibition mitigates vulnerable plaque formation induced by hyperhomocysteinemia through regulating lipid metabolism and inflammation” [Biochem. Pharmacol. 239 (2025) 117031] (Biochemical Pharmacology (2025) 239, (S0006295225002965), (10.1016/j.bcp.2025.117031))

The authors regret that an error occurred in the preparation of Figure 2, where the images of Oil red O staining from two different experimental groups were inadvertently duplicated. Upon reviewing the final published version, the authors identified that the images representing the Oil red O staining of AHM group and AHS group in Figure 2C were incorrectly duplicated due to an oversight during figure assembly. The corrected Figure 2 has now been prepared using the original data to ensure the accuracy of the results. This error does not affect the interpretation of the data, statistical analyses, or the conclusions of the study, and the corrected figure supports the original findings.